Published in Medical Patent Law Weekly, August 15th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Transition Therapeutics.
Report 1: Transition Therapeutics Inc. ("Transition") (TSX: TTH) announced today the filing of a Registration Statement on Form 40-F in connection with the filing of Transition's listing application for the NASDAQ Stock Market. The Form 40-F filing is being made with the United States Securities and Exchange Commission to register Transition's common shares in the United States.
Report 2: Transition Therapeutics Inc....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.